极早产儿迟发型脑膜炎的发病率及神经发育结局
该研究为多中心前瞻性队列的二次分析,纳入2003至2017年出生的22至26周胎龄早产儿13372例,随访至矫正年龄18至26个月。迟发型脑膜炎发病率为1%(167例),从2003年2%降至2017年0.4%(P<.001);迟发型脓毒症评估中腰椎穿刺执行率从2011年36%降至2017年24%(P<.001)。迟发型脑膜炎和迟发型脓毒症均与死亡或神经发育损害风险增加相关(aOR分别为1.53和1.41),且风险因病原体而异。作者认为当前诊断实践可能低估了迟发型脑膜炎与结局的真实关联。
要点
- 极早产儿迟发型脑膜炎发病率从2003年2%(95%CI 1%-3%)降至2017年0.4%(95%CI 0.7%-1.0%),P<.001。
- 迟发型脓毒症评估中腰椎穿刺执行率从2011年36%(95%CI 33%-40%)降至2017年24%(95%CI 21%-27%),P<.001;培养确诊迟发型脓毒症患儿中从58%(95%CI 51%-65%)降至45%(95%CI 38%-51%),P=.008。
- 迟发型脑膜炎最常見病原体为凝固酶阴性葡萄球菌(98/167,59%)、白色念珠菌(38/167,23%)和大肠埃希菌(27/167,16%)。
- 死亡或神经发育损害在凝固酶阴性葡萄球菌所致迟发型脑膜炎中为22/46(48%),其他细菌病原体为43/67(64%),真菌病原体为26/33(79%)。
- 与无感染患儿相比,迟发型脑膜炎患儿死亡或神经发育损害风险增加(aOR 1.53;95%CI 1.04-2.25),迟发型脓毒症无脑膜炎患儿风险亦增加(aOR 1.41;95%CI 1.29-1.54)。
适用人群与场景
- 22至26周胎龄的极早产儿,2003至2017年出生,随访至矫正年龄18至26个月;来自25个Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network中心。
研究设计与关键结果
- 研究类型:多中心前瞻性队列的二次分析;样本量13372例;中位胎龄25.4周(IQR 24.4-26.1周),6864例(51%)为男孩。
- 迟发型脑膜炎诊断167例(1%),迟发型脓毒症无脑膜炎4564例(34%),两者均无8641例(65%)。
- 迟发型脑膜炎发病率从2003年2%(95%CI 1%-3%)降至2017年0.4%(95%CI 0.7%-1.0%),P<.001。
- 迟发型脓毒症评估中腰椎穿刺执行率从2011年36%(95%CI 33%-40%)降至2017年24%(95%CI 21%-27%),P<.001;培养确诊迟发型脓毒症患儿中从58%(95%CI 51%-65%)降至45%(95%CI 38%-51%),P=.008。
- 腰椎穿刺执行率在不同中心间存在差异:所有迟发型脓毒症评估中为10%-59%(P<.001),培养确诊迟发型脓毒症患儿中为23%-79%(P<.001)。
- 167例迟发型脑膜炎中27例(16%)无并发迟发型脓毒症。
- 主要病原体:凝固酶阴性葡萄球菌98例(59%)、白色念珠菌38例(23%)、大肠埃希菌27例(16%)。
- 死亡或神经发育损害:凝固酶阴性葡萄球菌所致迟发型脑膜炎为22/46(48%),其他所有细菌病原体为43/67(64%),真菌病原体为26/33(79%)。
证据类型、等级与局限
- 证据类型:多中心前瞻性队列研究的二次分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,当前诊断实践可能低估了迟发型脑膜炎与极早产儿结局的真实关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Late-onset meningitis (LOM) has been associated with adverse neurodevelopmental outcomes in children born extremely preterm.
OBJECTIVE: To report the incidence of LOM during birth hospitalization and neurodevelopmental outcomes at 18 to 26 months' corrected age.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study is a secondary analysis of a multicenter prospective cohort of children born at 22 to 26 weeks' gestation between 2003 and 2017 with follow-up from 2004 to 2021. The study was conducted at 25 Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network centers.
EXPOSURES: Culture-confirmed LOM.
MAIN OUTCOMES AND MEASURES: Incidence and microbiology of LOM (2003-2017); lumbar puncture (LP) performance in late-onset sepsis (LOS) evaluations (2011-2017); composite outcome of death or neurodevelopmental impairment (NDI; 2004-2021).
RESULTS: Among 13 372 infants (median [IQR] gestational age, 25.4 [24.4-26.1] weeks; 6864 [51%] boys), LOM was diagnosed in 167 (1%); LOS without LOM in 4564 (34%); and neither LOS nor LOM in 8641 (65%). The observed incidence of LOM decreased from 2% (95% CI, 1%-3%) in 2003 to 0.4% (95% CI, 0.7%-1.0%) in 2017 (P < .001). LP performance in LOS evaluations decreased from 36% (95% CI, 33%-40%) in 2011 to 24% (95% CI, 21%-27%) in 2017 (P < .001). Among infants with culture-confirmed LOS, LP performance decreased from 58% (95% CI, 51%-65%) to 45% (95% CI, 38%-51%; P = .008). LP performance varied by center among all LOS evaluations (10%-59%, P < .001) and among those with culture-confirmed LOS (23%-79%, P < .001). LOM occurred in the absence of concurrent LOS in 27 of 167 cases (16%). The most common LOM isolates were coagulase-negative Staphylococcus (98 [59%]), Candida albicans (38 [23%]), and Escherichia coli (27 [16%]). Death or NDI occurred in 22 of 46 children (48%) with LOM due to coagulase-negative Staphylococcus, 43 of 67 (64%) due to all other bacterial pathogens, and 26 of 33 (79%) due to fungal pathogens. The adjusted relative risk of death or NDI was increased among children with LOM (aOR, 1.53; 95% CI, 1.04-2.25) and among those with LOS without LOM (aOR, 1.41; 95% CI, 1.29-1.54) compared with children with neither infection.
CONCLUSIONS AND RELEVANCE: In this cohort study, LP was performed with decreasing frequency, and the observed incidence of LOM also decreased. Both LOM and LOS were associated with increased risk of death or NDI; risk varied by LOM pathogen. The full association of LOM with outcomes of children born extremely preterm may be underestimated by current diagnostic practices.
参考来源
- Brumbaugh JE, Bell EF, Do BT, et al. Incidence of and Neurodevelopmental Outcomes After Late-Onset Meningitis Among Children Born Extremely Preterm. JAMA Netw Open. 2022. PMID: 36480199. doi:10.1001/jamanetworkopen.2022.45826
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。